Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EyeTel Imaging is a medical technology company specializing in the early detection of diabetic retinopathy through advanced retinal imaging systems. The company's flagship product, the DigiScope, is a semi-automated, non-mydriatic retinal camera designed for use in primary care settings to screen diabetic patients for vision-threatening disease. By utilizing proprietary image processing and a remote reading center model, EyeTel enables primary care physicians to provide specialist-level screenings, improving patient compliance and outcomes. The company was founded by ophthalmologists from the Wilmer Eye Institute at Johns Hopkins University and was later acquired by Welch Allyn to bolster their diagnostic imaging portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EyeTel Imaging.